Max Scherr

Max Scherr is a seasoned professional in biostatistics and health technology assessment (HTA) with extensive experience in the pharmaceutical industry. Currently serving as a Sr. Scientist/Biostatistician at MSD Switzerland since December 2021, Max has previously held positions at MSD, including Senior Manager HTA and Manager HTA, where expertise in evaluating and interpreting study data, dossier creation for benefit assessment, and leading cross-functional teams were demonstrated. Prior roles include project management at AMS Advanced Medical Services GmbH and internships focused on market access and outcomes research. Educational credentials include a Master of Science in Biostatistics from Heidelberg University and a Master of Public Health from Ludwig-Maximilians-Universität München, complemented by a Bachelor of Science in Economics from the same institution.